Results 31 to 40 of about 8,348,024 (289)

The histologic grading systems for intestinal acute graft-versus-host disease used in this study.

, 2021
The histologic grading systems for intestinal acute graft-versus-host disease used in this study.
Ernst Holler (136435), Daniela Weber (3470189), Katrin Hippe (11337273), Isabelle Ries (11337279), Helmut Neumann (391222), Arne Kandulski (11337282), Mario Schindeldecker (11337285), Andreas Kreft (385758), Maike Büttner-Herold (5280527), Eva Maria Wagner-Drouet (11337276)   +9 more
core   +1 more source

Initiation of acute graft-versus-host disease by angiogenesis [PDF]

Blood, 2016
Key PointsAngiogenesis preceded infiltration of inflammatory leukocytes during GVHD as well as during experimental colitis. Metabolic alterations and cytoskeleton changes occurred during early angiogenesis, but classical endothelial activation signs were absent.
Riesner, K., Shi, Y., Jacobi, A., Kraeter, M., Kalupa, M., McGearey, A., Mertlitz, S., Cordes, S., Schrezenmeier, J., Mengwasser, J., Westphal, S., Perez-Hernandez, D., Schmitt, C., Dittmar, G., Guck, J., Penack, O.   +15 more
openaire   +4 more sources

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

Haematologica, 2009
Background A variety of immune pathways can lead to graft-versus-host disease. A better understanding of the type of immune response causing graft-versus-host disease in defined clinical hematopoietic stem cell transplant settings is required to inform ...
Katie Matthews, ZiYi Lim, Behdad Afzali, Laurence Pearce, Atiyeh Abdallah, Shahram Kordasti, Antonio Pagliuca, Giovanna Lombardi, J. Alejandro Madrigal, Ghulam J. Mufti, Linda D. Barber   +10 more
doaj   +1 more source

Advances in the treatment of acute graft‐versus‐host disease [PDF]

Journal of Cellular and Molecular Medicine, 2013
AbstractAllogeneic hematopoietic stem cell transplantation (HSCT) has been widely used for the treatment of hematologic malignant and non‐malignant hematologic diseases and other diseases. However, acute graft‐versus‐host disease (GVHD) is a life‐threatening complication of allogeneic transplantation.
Qian, Liren, Wu, Zhengcheng, Shen, Jianliang   +2 more
openaire   +2 more sources

Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?

Clinics, 2010
INTRODUCTION: Minor histocompatibility antigen HA-1 (MiHAg-HA-1) disparity between a patient and his or her human leukocyte antigen (HLA) genoidentical donor has been widely associated with an increased risk of graft-versus-host disease following ...
Mohamed Hichem Sellami, Lamia Torjemane, Alejandro Espadas de Arias, Houda Kaabi, Saloua Ladeb, Francesca Poli, Tarek Ben Othmane, Slama Hmida   +7 more
doaj   +1 more source

acute exacerbation of graft-versus-host disease

, 2023
Photography at presentation. (A) Image of right eye (RE) showed prominent anterior chamber inflammation with posterior synechiae. Band keratopathy was due to ocular graft-versus-host disease and keratoconjunctivitis sicca.
Chen-Yu Lin (14613215)
core   +1 more source

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

Haematologica, 2011
Background The 2005 National Institutes of Health Consensus Development Conference on chronic graft-versus-host disease proposed major changes in the classification and grading of severity of chronic graft-versus-host disease.Design and Methods We aimed ...
Joseph Pidala, Jongphil Kim, Claudio Anasetti, Taiga Nishihori, Brian Betts, Teresa Field, Janelle Perkins   +6 more
doaj   +1 more source

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [PDF]

, 2004
We report the outcomes after reduced-intensity conditioning allogeneic stem cell transplantation (RIT) for non-Hodgkin lymphoma (NHL) in 88 patients (low-grade NHL [LG-NHL], n = 41; high-grade NHL [HG-NHL], n = 37; mantle cell lymphoma [MCL], n = 10 ...
Mahendra, P, Smith, GM, Cook, G., Hatton, C., Tighe, J., Morris, E., Goldstone, A, Peggs, K., Cook, G, Mahendra, Premini, Hunter, A., Mackinnon, S, Milligan, D., Smith, G.M., Goldstone, A., Chopra, R, Hunter, A, Linch, D., Parker, A, Linch, D, Morris, E, Hunter, A.H., Milligan, D, Thomson, K, Parker, A., Peggs, K, Chopra, R., Thomson, K., Craddock, C., Hatton, C, Mackinnon, S., Milligan, Donald, Mahendra, P., Schey, S., Craddock, Charles; id_orcid, Craddock, C, Schey, S, Tighe, J   +37 more
core   +1 more source

Acute graft-versus-host disease in children [PDF]

Bone Marrow Transplantation, 2007
Acute graft-versus-host disease (GVHD) is one of the major complications of hematopoietic stem cell transplantation. Many variables including stem cell source, age of donor and recipient, preparative regimen and prophylaxis can impact the likelihood and severity of GVHD.
openaire   +2 more sources

Recombinant human thrombopoietin reduces the risk of acute graft-versus-host-disease and its mechanisms

, 2023
Recombinant human thrombopoietin reduces the risk of acute graft-versus-host-disease and its mechanismsObjective: Acute graft-versus-host-disease (aGVHD) is an important complication that is observed after allogeneic hematopoietic stem cell ...
Hairong Fei (16720680), Sizhou Feng (15204806), Chunting Zhao (818245), Xiaolin Ma (701778), Xiaodan liu (5541338), Erlie Jiang (4040900)   +5 more
core   +1 more source